BioNTech SE is 8.3x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($21.79 B vs $2.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TARS | BNTX |
|---|---|---|
| Market cap | $2.64 B | $21.79 B |
| US-listed rank | #1904 | #587 |
| Revenue (latest FY) | $451.36M | - |
| Net income (latest FY) | -$66.00M | - |
| Net margin | -14.6% | - |
| SEC filings | 617 | 548 |
BioNTech SE is 8.3x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($21.79 B vs $2.64 B).
Full pages: Tarsus Pharmaceuticals, Inc. and BioNTech SE, or browse the full rankings.